These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 34942281)
1. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study. Chan J; Brown E; Dennis K; Milosevic M; Brundage M Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281 [TBL] [Abstract][Full Text] [Related]
2. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study. Shack L; Lu S; Weeks LA; Craighead P; Kerba M Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795 [TBL] [Abstract][Full Text] [Related]
3. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study. McBride ML; Groome PA; Decker K; Kendell C; Jiang L; Whitehead M; Li D; Grunfeld E; BMC Cancer; 2019 Jul; 19(1):659. PubMed ID: 31272420 [TBL] [Abstract][Full Text] [Related]
4. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach. Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847 [TBL] [Abstract][Full Text] [Related]
5. Measuring progress in cancer survival across Canadian provinces: Extending the cancer survival index to further evaluate cancer control efforts. Ellison LF Health Rep; 2022 Jun; 33(6):17-29. PubMed ID: 35876613 [TBL] [Abstract][Full Text] [Related]
6. Changes in the use of radiotherapy in Ontario 1984-1995. Mackillop WJ; Zhou S; Groome P; Dixon P; Cummings BJ; Hayter C; Paszat L Int J Radiat Oncol Biol Phys; 1999 May; 44(2):355-62. PubMed ID: 10760431 [TBL] [Abstract][Full Text] [Related]
7. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia. Tyldesley S; Delaney G; Foroudi F; Barbera L; Kerba M; Mackillop W Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1507-15. PubMed ID: 20605338 [TBL] [Abstract][Full Text] [Related]
8. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers. Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661 [TBL] [Abstract][Full Text] [Related]
9. Assessing a Suitable Radiotherapy Utilisation Benchmark for Older Patients With Head and Neck Cancer. Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M Clin Oncol (R Coll Radiol); 2024 Oct; 36(10):e381-e387. PubMed ID: 39013658 [TBL] [Abstract][Full Text] [Related]
10. Inter- and intra-provincial variation in screen-detected breast cancer across five Canadian provinces: a CanIMPACT study. Winget M; Yuan Y; McBride ML; Kendell C; Decker KM; Grunfeld E; Groome PA; Can J Public Health; 2020 Oct; 111(5):794-803. PubMed ID: 32020541 [TBL] [Abstract][Full Text] [Related]
11. Linking national immigration data to provincial repositories: The case of Canada. Urquia ML; Walld R; Wanigaratne S; Eze ND; Azimaee M; McDonald JT; Guttmann A Int J Popul Data Sci; 2021 May; 6(1):1412. PubMed ID: 34104802 [TBL] [Abstract][Full Text] [Related]
12. Survival patterns for the top four cancers in Canada: the effects of age, region and period. Ugnat AM; Xie L; Semenciw R; Waters C; Mao Y Eur J Cancer Prev; 2005 Apr; 14(2):91-100. PubMed ID: 15785312 [TBL] [Abstract][Full Text] [Related]
13. Association between age and the utilization of radiotherapy in Ontario. Tyldesley S; Zhang-Salomons J; Groome PA; Zhou S; Schulze K; Paszat LF; Mackillop WJ Int J Radiat Oncol Biol Phys; 2000 May; 47(2):469-80. PubMed ID: 10802375 [TBL] [Abstract][Full Text] [Related]
14. Waiting for radiotherapy in Ontario. Mackillop WJ; Fu H; Quirt CF; Dixon P; Brundage M; Zhou Y Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):221-8. PubMed ID: 8083117 [TBL] [Abstract][Full Text] [Related]
15. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer. Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015 [TBL] [Abstract][Full Text] [Related]
16. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review. Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia. Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070 [TBL] [Abstract][Full Text] [Related]
18. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study. McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G; Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049 [TBL] [Abstract][Full Text] [Related]
19. Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios. Huỳnh C; Kisely S; Rochette L; Pelletier É; Morrison KB; Li S; Hopkin G; Smith M; Burchill C; Lin E; Asbridge M; Jutras-Aswad D; Lesage A Can J Psychiatry; 2022 Feb; 67(2):117-129. PubMed ID: 34569874 [TBL] [Abstract][Full Text] [Related]